We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+21.62%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.77B
AUM Growth
+$131M
Cap. Flow
-$102M
Cap. Flow %
-5.74%
Top 10 Hldgs %
16.77%
Holding
386
New
51
Increased
133
Reduced
142
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 15.79%
2 Healthcare 15.31%
3 Consumer Discretionary 13.28%
4 Industrials 13.26%
5 Financials 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAZZ icon
26
Jazz Pharmaceuticals
JAZZ
$15.5B
$15.5M 0.87%
168,254
-8,394
-5% -$677K
ANSS
27
DELISTED
Ansys
ANSS
$15.2M 0.86%
175,736
+2,170
+1% +$181K
MGAM
28
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
$14.8M 0.84%
429,680
-275,491
-39% -$9.41M
AWAY
29
DELISTED
HOMEAWAY INC COM
AWAY
$14.1M 0.8%
504,206
+119,140
+31% +$3.69M
PAG icon
30
Penske Automotive Group
PAG
$13.3B
$13.6M 0.77%
317,492
+33,598
+12% +$1.29M
CPHD
31
DELISTED
Cepheid Inc
CPHD
$13.6M 0.77%
347,410
-11,497
-3% -$417K
CAVM
32
DELISTED
Cavium, Inc.
CAVM
$13.6M 0.77%
328,963
-35,013
-10% -$1.32M
LL
33
DELISTED
LL Flooring Holdings, Inc.
LL
$13.5M 0.76%
126,350
+45,849
+57% +$4.44M
IPGP icon
34
IPG Photonics
IPGP
$4.43B
$13.1M 0.74%
233,231
-13,201
-5% -$772K
AEGR
35
DELISTED
Aegerion Pharmaceuticals
AEGR
$13.1M 0.74%
153,197
-20,189
-12% -$1.71M
KATE
36
DELISTED
Kate Spade & Company
KATE
$12.9M 0.73%
513,136
-217,985
-30% -$5.31M
RRGB icon
37
Red Robin
RRGB
$130M
$12.7M 0.72%
178,798
-23,590
-12% -$1.48M
WAIR
38
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$12.5M 0.71%
+598,751
New +$11.8M
USG
39
DELISTED
Usg
USG
$12.4M 0.7%
433,332
-57,305
-12% -$1.46M
AFSI
40
DELISTED
AmTrust Financial Services, Inc.
AFSI
$12.2M 0.69%
625,812
-47,467
-7% -$883K
INSY
41
DELISTED
Insys Therapeutics, Inc.
INSY
$12.1M 0.69%
1,040,952
-197,136
-16% -$1.62M
GNC
42
DELISTED
GNC Holdings, Inc.
GNC
$12M 0.68%
220,532
-116,497
-35% -$5.95M
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$11.7M 0.66%
169,543
+120,368
+245% +$5.94M
IONS icon
44
Ionis Pharmaceuticals
IONS
$8.99B
$11.5M 0.65%
305,945
+33,018
+12% +$986K
PFPT
45
DELISTED
Proofpoint, Inc.
PFPT
$11.5M 0.65%
357,466
+348,936
+4,091% +$9.82M
CUBE icon
46
CubeSmart
CUBE
$9.48B
$11.5M 0.65%
643,070
+80,440
+14% +$1.37M
XXIA
47
DELISTED
Ixia
XXIA
$11.5M 0.65%
731,946
-60,835
-8% -$937K
CUBI icon
48
Customers Bancorp
CUBI
$2.65B
$11.4M 0.65%
782,037
+293,505
+60% +$4.46M
LAD icon
49
Lithia Motors
LAD
$7.65B
$11.4M 0.64%
156,114
-10,600
-6% -$693K
AYI icon
50
Acuity Brands
AYI
$9.99B
$11.3M 0.64%
123,186
-12,411
-9% -$1.08M

Similar funds

Emerald Advisers's Q3 2013 Portfolio in Review

As of Q3 2013, Emerald Advisers held 386 positions worth $1.77B, up 8% from $1.64B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers withdrew a net $102M in Q3 2013, closing 44 positions and reducing 142 holdings. Its most notable exit was SOURCEFIRE INC COM STK, an estimated $22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Imperva, Inc. worth $11M.

  • Emerald Advisers's largest Q3 2013 buy was Imperva, Inc.: 260,820 shares worth $11M.
  • Emerald Advisers added most to Proofpoint, Inc. in Q3 2013, an estimated $9.82M increase.
  • Emerald Advisers's biggest Q3 2013 reduction was WESCO International, cutting an estimated $13M.
  • Emerald Advisers fully exited SOURCEFIRE INC COM STK in Q3 2013, selling an estimated $22M.
  • Emerald Advisers's ten largest holdings make up 17% of its $1.77B portfolio in Q3 2013.
  • Emerald Advisers opened 51 new positions and closed 44 in Q3 2013.
  • Emerald Advisers's portfolio value rose 8% quarter-over-quarter to $1.77B.

Based on Emerald Advisers's 13F filing for Q3 2013, filed 31 Oct 2013.